Discuss cutting-edge topics with CGT experts during ASGCT's Insights Week! Choose from five daily sessions between Oct. 16-20
DEI Career Development
Not a member? Anyone with a demonstrated professional interest in gene and cell therapy is invited to join—apply now and earn eligiblity for ASGCT's funded awards.
Join Today!
Supporting six members who are working toward independence in their gene and cell therapy careers.
ASGCT has created three awards totaling $250,000 as part of the Society's commitment to promoting justice and equity in gene and cell therapy research.
This honorific award recognizes individuals for their outstanding contributions toward the mentorship, training, education, or support of students, residents, fellows, trainees, or other early career professionals either through formal training programs or through non-traditional means.
This honorific award recognizes individuals, organizations, or other entities for their outstanding contributions toward the Society’s principles and programs advancing diversity, equity, and inclusion.
This honorific award recognizes individuals for their outstanding contributions to ASGCT and their commitment to Society’s mission to advance knowledge, education, and awareness of gene and cell therapy.
NEW in 2023, this award highlights the contributions of leading early-career authors to the Molecular Therapy family of journals.
NEW in 2023, the ASGCT Catalyst Award recognizes an ASGCT member or team of professionals who have had an extraordinary impact on the translation of gene and cell therapies.
Named for the first person to study viral mediated gene therapy for muscular dystrophy in humans, and the principal investigator in the study that led to the FDA approval of Zolgensma to treat SMA, the Jerry Mendell Award for Translational Science recognizes the extensive work required to bring gene and cell therapies to clinical trial. Supported by Dr. Suku and Ann Nagendran
The ASGCT Outstanding Achievement Award recognizes an ASGCT Member who has achieved a pioneering research success, a specific high impact accomplishment, or a lifetime of significant contributions to the field of gene and cell therapy. It is the Society’s highest honor.
Several Outstanding New Investigators are recognized each year based on their contributions to the field of gene and cell therapy. Investigators from academia, research foundations, government, and industry are all eligible to be nominated for awards.
Named for its inaugural co-recipient and tireless gene therapy advocate, the Society’s Sonia Skarlatos Public Service Award recognizes a person or group that has consistently fostered and enhanced the field of gene and cell therapy through governmental agencies, public policy groups, public education, or non-governmental charitable organizations.
ASGCT supports the travel of approximately 150 Associate Members each year through the Meritorious Abstract Travel Award program. Recipients will receive a certificate and a travel reimbursement stipend of up to $500 for domestic awardees and $600 for international awardees to the 21st Annual Meeting.
Each year the ASGCT Abstract Review Committee for the Annual Meeting selects the top six abstracts submitted by students and fellows to receive Excellence in Research Awards.
The top poster presentations from each of the three poster sessions that occur during the ASGCT Annual Meeting are awarded Outstanding Poster Presentation Awards.
Established in 2022, the ASGCT Founders Award recognizes a pioneering contributor to the gene and cell therapy field. It is among the Society’s highest honors and the recipient presents a keynote lecture highlighting their accomplishments that led to the award.
First introduced in 2016, the ASGCT Underrepresented Population Travel Awards honor and support ASGCT Associate Members who submitted abstracts to the Annual Meeting.
This award recognizes scientists who do an outstanding job of communicating their work in gene and cell therapy, particularly those who speak to a broader audience of scientists and non-scientists.
Watch on demand through Oct. 23!
© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico